Treatment of patients with anemia of malignancy with recombinant human erythropoietin.
Herrmann
F
F
Department of Internal Medicine I, University of Freiburg, Marburg, FRG.
Oster
W
W
Mertelsmann
R
R
D000740:Anemia / Q000188:drug therapy*; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin